United States & Anderson

United States: The United States, through its Department of Commerce, is investing $2 billion in quantum computing firms to secure its leadership in emerging technologies, create jobs, and enhance national security, particularly in competition with China.

Anderson: Anderson>>> is a new subsidiary launched by IBM>>> with $1 billion in government incentives and an additional $1 billion from IBM>>>, aiming to be America's first dedicated quantum chip manufacturing facility.

United States: The United States is positioned to secure global quantum leadership and manufacture most of the world's quantum wafers through the establishment of Anderson, bolstering its economic growth and national security.

Anderson: Anderson is a new standalone company formed by IBM with support from the United States — United States Department of Commerce, set to become America's first pure-play quantum foundry. It will operate a 300-millimeter quantum wafer foundry, aiming to catalyze the production of scalable quantum technologies within the United States.

United States: The investment by IBM aims to advance quantum leadership anchored in the United States, potentially boosting the nation's technological standing and economic competitiveness in this critical sector.

Anderson: Anderson is set to become the world's first pure-play quantum wafer foundry, with IBM contributing $1 billion and significant intellectual property, positioning it as a key player in quantum manufacturing.

United States: The United States is the market where the United States — Food and Drug Administration's clearance allows GE HealthCare's software to be used, impacting over 2 million U.S. patients annually who receive radiation therapy.

Anderson: Anderson, General Manager of MIM at GE HealthCare, commented on how MIM Contour ProtégéAI+ 2.0 can help reduce treatment planning time for care teams.